Related Experiment Video
Updated: May 27, 2026

Preparation of Cell-lines for Conditional Knockdown of Gene Expression and Measurement of the Knockdown Effects on E4orf4-Induced Cell Death
Published on: October 21, 2012
Lentivirus-mediated RNA interference of E2F-1 suppresses Tca8113 cell proliferation
Hua Yuan1, Fei Jiang, Ruixia Wang
1Institute of Dental Research, Nanjing Medical University, Nanjing, Jiangsu 210029, PR China.
Abstract:
In most types of human cancer, inactivation of pRb/E2F complexes occurs, and released E2Fs initiate transcription of genes required for cell cycle progression. Evidence reveals that phosphorylated pRb deregulates E2F-1, and the levels of E2F-1 expression can accurately predict prognosis of oral squamous cell carcinoma (OSCC). Paradoxically, numerous reports indicate that E2F-1 is also capable of inducing apoptosis under certain cellular circumstances. In the present study, lentivirus-mediated shRNA was used to downregulate endogenous E2F-1 expression in order to study the function of E2F-1 in the pRb/E2F-1 pathway in the OSCC cell line Tca8113, and to investigate the alteration of Tca8113 cells in proliferation and apoptosis. The data from real-time quantitative RT-PCR and Western blot analysis showed that E2F-1-shRNA led to the inhibition of endogenous E2F-1 mRNA and protein expression, and E2F-1 may be associated with proliferation and apoptosis pathways. Growth kinetics data showed that Tca8113-E2F-1-shRNA cells presented more active proliferation properties than Tca8113-NC cells, and flow cytometry data demonstrated that the percentages of cells in the G1 phase, G2 phase and undergoing apoptosis differed between groups. In conclusion, silencing of E2F-1 inhibits proliferation and induces apoptosis. E2F-1 may also be involved in multi-level regulation networks; therefore, its role in OSCC requires further clarification.
Insights
Silencing E2F-1 in oral squamous cell carcinoma (OSCC) cells inhibits proliferation and induces apoptosis. Further research is needed to clarify E2F-1
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- pRb/E2F complexes regulate cell cycle progression in human cancers.
- E2F-1 expression levels correlate with oral squamous cell carcinoma (OSCC) prognosis.
- E2F-1 has a dual role, potentially promoting cell cycle progression or apoptosis.
Purpose of the Study:
- To investigate the function of E2F-1 in the pRb/E2F-1 pathway in OSCC.
- To analyze the impact of E2F-1 downregulation on OSCC cell proliferation and apoptosis.
- To elucidate the role of E2F-1 in the Tca8113 OSCC cell line.
Main Methods:
- Lentivirus-mediated shRNA was employed to downregulate endogenous E2F-1 expression.
- Real-time quantitative RT-PCR and Western blot analysis were used to confirm E2F-1 inhibition.
- Cell proliferation was assessed using growth kinetics, and apoptosis was analyzed via flow cytometry.
Main Results:
- E2F-1-shRNA effectively inhibited E2F-1 mRNA and protein expression in Tca8113 cells.
- Silencing E2F-1 led to more active proliferation properties in Tca8113 cells.
- Differences in cell cycle distribution (G1, G2 phases) and apoptosis rates were observed between E2F-1 silenced and control groups.
Conclusions:
- Downregulation of E2F-1 inhibits proliferation and induces apoptosis in OSCC cells.
- E2F-1 appears to be involved in complex regulatory networks affecting proliferation and apoptosis.
- The precise role of E2F-1 in OSCC warrants further comprehensive investigation.
Related Concept Videos
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Inhibition of Cdk Activity
Inhibition of CDK Activity
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Negative Regulator Molecules

